170 related articles for article (PubMed ID: 24112437)
1. The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma.
Bayo J; Marrodán M; Aquino JB; Silva M; García MG; Mazzolini G
Liver Int; 2014 Mar; 34(3):330-42. PubMed ID: 24112437
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
4. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
[TBL] [Abstract][Full Text] [Related]
5. Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
Yan C; Yang M; Li Z; Li S; Hu X; Fan D; Zhang Y; Wang J; Xiong D
Biomaterials; 2014 Mar; 35(9):3035-43. PubMed ID: 24406219
[TBL] [Abstract][Full Text] [Related]
6. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.
Li GC; Ye QH; Dong QZ; Ren N; Jia HL; Qin LX
Oncol Rep; 2013 Feb; 29(2):713-9. PubMed ID: 23232668
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Schmohl KA; Müller AM; Wechselberger A; Rühland S; Salb N; Schwenk N; Heuer H; Carlsen J; Göke B; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2015 Dec; 22(6):941-52. PubMed ID: 26307023
[TBL] [Abstract][Full Text] [Related]
9. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.
Keung EZ; Nelson PJ; Conrad C
Stem Cells; 2013 Feb; 31(2):227-35. PubMed ID: 23132810
[TBL] [Abstract][Full Text] [Related]
10. The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
Alshareeda AT; Sakaguchi K; Abumaree M; Mohd Zin NK; Shimizu T
PLoS One; 2017; 12(8):e0184004. PubMed ID: 28850615
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
[TBL] [Abstract][Full Text] [Related]
12. Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma.
Jeong KY; Lee EJ; Kim SJ; Yang SH; Sung YC; Seong J
Int J Cancer; 2015 Aug; 137(3):721-30. PubMed ID: 25639194
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma.
Aquino JB; Bolontrade MF; García MG; Podhajcer OL; Mazzolini G
Gene Ther; 2010 Jun; 17(6):692-708. PubMed ID: 20220785
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
[TBL] [Abstract][Full Text] [Related]
15. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies.
Hajighasemlou S; Pakzad S; Ai J; Muhammadnejad S; Mirmoghtadaei M; Hosseinzadeh F; Gharibzadeh S; Kamali A; Ahmadi A; Verdi J
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1627-1631. PubMed ID: 29936790
[TBL] [Abstract][Full Text] [Related]
16. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
Zhang J; Hou L; Wu X; Zhao D; Wang Z; Hu H; Fu Y; He J
Mol Cell Biochem; 2016 May; 416(1-2):193-203. PubMed ID: 27142531
[TBL] [Abstract][Full Text] [Related]
18. Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.
Bayo J; Fiore E; Aquino JB; Malvicini M; Rizzo M; Peixoto E; Andriani O; Alaniz L; Piccioni F; Bolontrade M; Podhajcer O; Garcia MG; Mazzolini G
PLoS One; 2014; 9(4):e95171. PubMed ID: 24736611
[TBL] [Abstract][Full Text] [Related]
19. Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells.
Nystedt J; Anderson H; Tikkanen J; Pietilä M; Hirvonen T; Takalo R; Heiskanen A; Satomaa T; Natunen S; Lehtonen S; Hakkarainen T; Korhonen M; Laitinen S; Valmu L; Lehenkari P
Stem Cells; 2013 Feb; 31(2):317-26. PubMed ID: 23132820
[TBL] [Abstract][Full Text] [Related]
20. A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs.
Chen X; Lin X; Zhao J; Shi W; Zhang H; Wang Y; Kan B; Du L; Wang B; Wei Y; Liu Y; Zhao X
Mol Ther; 2008 Apr; 16(4):749-56. PubMed ID: 18362930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
